Company intelligence / Profile preview

Astellas Venture Management

South San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Astellas Venture Management is the dedicated venture investment arm of Astellas Pharma, specializing in early-stage, pre-clinical biotech investments. It does not itself develop drugs but invests in companies whose platforms and programs are at preclinical and early discovery stages, particularly those aligned with Astellas Pharma’s R&D strategy[1][4].

Modalities: Small moleculeMonoclonal antibodyGene therapyAntibody-drug conjugateCell therapyProteinRNA therapy
Industry: Investors

Partnerships

Portfolio partnerships with early-stage biotech companies including Casma Therapeutics, NeoPhore, Catamaran Bio, Heartseed, and others[5][6].

Beyond the preview

Go deeper on Astellas Venture Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astellas Venture Management.

Explore the full profile